China to pursue commercial health insurance to ease public strain, support drug innovation
China's 2026 government work report includes plans to develop commercial health insurance, aiming to supplement the existing public system and support innovation in drugs and medical devices. Premier Li Qiang announced the initiative in response to an aging population and slower government revenue growth, which are straining the basic medical insurance fund. Healthcare expenditure is rising, and the surplus in the basic medical insurance fund has been declining. While basic medical insurance covers over 95% of the population, demand is growing for treatments and services beyond its scope, particularly among middle and high-income individuals. The move is intended to ease the financial burden on the state and better meet the diverse healthcare needs of the population.